Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. AMO (Hangzhou) Co., Ltd.
483
•AMO (Hangzhou) Co., Ltd.•July 2, 2019

FDA 483 - AMO (Hangzhou) Co., Ltd. - July 02, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of AMO (Hangzhou) Co., Ltd., a sterile OTC drug manufacturer, revealed significant deficiencies. Observations included inadequate controls over computer systems leading to deleted data and shared administrator passwords, as well as insufficient validation of aseptic processes. Additionally, the quality control unit's procedures for aseptic interventions and environmental controls were found to be lacking or not fully followed.

Company
AMO (Hangzhou) Co., Ltd.
Inspection Date
July 2, 2019
Product Type
Drugs
Office
Office of Biological Products Operations - Division I
Person
  • Joel D. Hustedt
Open in Dashboard

ID · 06165aca-e33b-4b83-8fc6-b42fc3bc56dd

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.